Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $35.7 Million - $60.8 Million
-186,769 Reduced 23.79%
598,200 $195 Million
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $72.9 Million - $97.7 Million
-452,772 Reduced 36.58%
784,969 $150 Million
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $28.5 Million - $41.7 Million
146,691 Added 13.44%
1,237,741 $246 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $67.7 Million - $91.9 Million
-303,717 Reduced 21.78%
1,091,050 $311 Million
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $67.1 Million - $83.3 Million
382,374 Added 37.77%
1,394,767 $302 Million
Q4 2022

Feb 14, 2023

SELL
$204.38 - $296.82 $160 Million - $233 Million
-784,628 Reduced 43.66%
1,012,393 $208 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $277 Million - $440 Million
-1,417,657 Reduced 44.1%
1,797,021 $500 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $72.8 Million - $135 Million
627,712 Added 24.26%
3,214,678 $615 Million
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $62.7 Million - $102 Million
-490,286 Reduced 15.93%
2,586,966 $536 Million
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $23.6 Million - $34.5 Million
-142,722 Reduced 4.43%
3,077,252 $549 Million
Q3 2021

Nov 15, 2021

SELL
$163.99 - $235.57 $12.6 Million - $18.1 Million
-76,720 Reduced 2.33%
3,219,974 $663 Million
Q2 2021

Aug 16, 2021

SELL
$131.45 - $201.49 $84.4 Million - $129 Million
-642,323 Reduced 16.31%
3,296,694 $625 Million
Q1 2021

May 17, 2021

BUY
$92.73 - $142.05 $135 Million - $207 Million
1,458,245 Added 58.78%
3,939,017 $513 Million
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $167 Million - $257 Million
2,480,772 New
2,480,772 $257 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.